References
- Cao SL, Ren XW, Zhang QZ, Chen E, Xu F, Chen J, Liu LC, Jiang XG. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate. Int J Pharm 2009; 365: 109–15
- Christian DA, Cai S, Bowen DM, Kim Y, Pajerowski JD, Discher DE. Polymersome carriers: From self-assembly to siRNA and protein therapeutics. Eur J Pharm Biopharm 2009; 71: 463–74
- Coimbra PA, De Sousa HC, Gil MH. Preparation and characterization of flurbiprofen-loaded poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres. J Microencapsul 2008; 25: 170–78
- Colletier JP, Chaize B, Winterhalter M, Fournier D. Protein encapsulation in liposomes: Efficiency depends on interactions between protein and phospholipid bilayer. BMC Biotechnol 2002; 2: 9
- Discher DE, Eisenberg A. Polymer vesicles. Science 2002; 297: 967–73
- Edsman K, Carlfors J, Harju K. Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use Katarina Edsmana, Johan Carlforsa, b and Kaisa Harjub, 1. Int J Pharm 1996; 219: 139–49
- Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2003; 2: 214–21
- Madan M, Bajaj A, Lewis S, Udupa N, Baig JA. In situ forming polymeric drug delivery systems. Indian J Pharm Sci 2009; 71: 242–51
- Malik NN. Drug discovery: Past, present and future. Drug Discov Today 2008; 13: 909–12
- Meng F, Engbers GH, Feijen J. Biodegradable polymersomes as a basis for artificial cells: Encapsulation, release and targeting. J Control Release 2005; 101: 187–98
- Mishima K, Tsukikawa H, Miura I, Inada K, Abe K, Matsumoto Y, Egashira N, Iwasaki K, Fujiwara M. Ameliorative effect of NC-1900, a new AVP4-9 analog, through vasopressin V1A receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze. Neuropharmacol 2003; 44: 541–52
- Nanjawade BK, Manvi FV, Manjappa AS. In situ-forming hydrogels for sustained ophthalmic drug delivery. J Control Release 2007; 122: 119–34
- O’Neil CP, Suzuki T, Demurtas D, Finka A, Hubbell JA. A novel method for the encapsulation of biomolecules into polymersomes via direct hydration. Langmuir 2009; 25: 9025–29
- Pang Z, Lu W, Gao H, Hu K, Chen J, Zhang C, Gao X, Jiang X, Zhu C. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. J Control Release 2008; 128: 120–7
- Parveen S, Sahoo SK. Nanomedicine: Clinical applications of polyethylene glycol conjugated proteins and drugs. Clin Pharmacokinet 2006; 45: 965–88
- Paulsson M, Hagerstrom H, Edsman K. Rheological studies of the gelation of deacetylated gellan gum (Gelrite) in physiological conditions. Eur J Pharm Sci 1999; 9: 99–105
- Pisal DS, Kosloski MP, Balu-Iyer SV. Delivery of therapeutic proteins. J Pharm Sci 2010; 99: 2557–75
- Pygall SR, Griffiths PC, Wolf B, Timmins P, Melia CD. Solution interactions of diclofenac sodium and meclofenamic acid sodium with hydroxypropyl methylcellulose (HPMC). Int J Pharm 2011; 405: 55–62
- Roberts MJ, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 2002; 54: 459–76
- van Dongen SF, de Hoog HP, Peters RJ, Nallani M, Nolte RJ, van Hest JC. Biohybrid polymer capsules. Chem Rev 2009; 109: 6212–74
- Volodkin DV, Larionova NI, Sukhorukov GB. Protein encapsulation via porous CaCO3 microparticles templating. Biomacromolecules 2004a; 5: 1962–72
- Volodkin DV, Petrov AI, Prevot M, Sukhorukov GB. Matrix polyelectrolyte microcapsules: New system for macromolecule encapsulation. Langmuir 2004b; 20: 3398–406
- Wilhelm M, Zhao CL, Wang Y, Xu R, Winnik MA, Mura JL, Riess G, Croucher MD. Poly(styrene-ethylene oxide) block copolymer micelle formation in water: A fluorescence probe study. Macromolecules 1991; 24: 1033–40
- Xie YL, Lu W, Jiang XG. Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice. Behav Brain Res 2006; 173: 76–84